![](/img/cover-not-exists.png)
Letter to the Editor: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival
Nuijten, M, Mickisch, GVolume:
102
Year:
2010
Pages:
1
DOI:
10.1038/sj.bjc.6605613
File:
PDF, 56 KB
2010